Climate change has brought both fiercer rains and deeper droughts, leaving the city with brush like kindling—and the ...

By Linda Naa Deide Aryeetey Accra, Jan 21 GNA- The 4th Global Non-Communicable Disease (NCD) Alliance Forum slated for February 13 to 15, is to be hosted in Kigali, Rwanda. This makes it the first ...

This article seems funny, though, but I am tempted to do this write-up due to the many female students I have seen who are glued to their gum.

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

New Insights Into the Biology and Risk Factors of Childhood Obesity Jan. 15, 2025 — A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with ...

While this microbial exchange may sound unusual, it’s not necessarily a bad thing. Sharing microbiomes through activities ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

Medical experts have urged a shift away from the Body Mass Index (BMI) as the main yardstick to determine obesity as it does not factor in body fat levels. The prevalent method is so flawed that it ...

VK-2735 is under clinical development by Viking Therapeutics and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) ...

Mazdutide is under clinical development by Eli Lilly and Co and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

GAUA UniMAC holds career guidance workshop for Osu Presby students 21-01-25 ...